MediWound Cash Flow - Quarterly (NASDAQ:MDWD)

Add to My Stocks
$6.4 $0 (0%) MDWD stock closing price Sep 20, 2018 (Closing)

The MediWound cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about MediWound profits and MediWound debt. MediWound had cash and cash equivalents of $36.07M at beginning of the quarter and $5.66M at quarter end of 2018 Q2. MediWound cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. MediWound had an outflow of $-8.82M from operating activities, $- spend due to financing activities, and $-21.49M outflow due to investing activities till 2018 Q2.

View and download details of MediWound cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-2.24M--2.44M-2.94M-2.46M-1.53M1.98M1.37M1.14M-0.79M
Cash From (used in) Discontinued Operations--6.05M7.5M------
Other Adjustments Net1.83M-1.52M2.74M1.94M--0.13M3.02M2.04M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.31M-0.11M-1.04M-0.86M-0.36M-0.19M-0.67M-0.64M-0.44M-0.32M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-21.17M-22.84M1.16M-13.83M-16.83M-19.84M2.11M-25.23M-23.73M-29.21M
Other Cash Inflow (Outflow) from Investment Activities-0.01M---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--22.66M22.8M------
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-----0.03M-----
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.13M-0.01M--------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year36.07M28.86M42.5M25.42M7.05M-3.66M2.72M--
Cash & Equivalents at Year End5.66M9.99M36.06M25.4M2.77M4.15M28.86M5.18M10.59M9.02M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Durect financial analysis

MediWound stock price history provides insight into historical stock price fluctuations, and MediWound stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • MediWound had a Net Change in Cash and Cash Equivalents of $-30.41M in the latest quarter 2018 Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the MediWound stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: MediWound reported a negative operating cash flow of $-8.82M till 2018 Q2 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-21.49M for MDWD stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for MediWound.

Key Financial Ratios For MediWound Cash Flow

Quarterly Cash Flow Statements For Mediwound Ltd Peers

Durect cash flow, NUO THERAPT-OLD cash flow, Recro Pharma cash flow, Uluru cash flow